COVID-19 Infection-Preventing Clinical Deterioration.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

4 citing papers in PubMed.

1. Influence of COVID-19 on the sustainability of livestock performance and welfare on a global scale.Tropical animal health and production · 2022
   Review
2. Viruses in fermented foods: are they good or bad? Two sides of the same coin.Food microbiology · 2021
   Review
3. The influence of selection bias on identifying an association between allergy medication use and SARS-CoV-2 infection.EClinicalMedicine · 2021
   Article
4. Repurposing of CNS drugs to treat COVID-19 infection: targeting the sigma-1 receptor.European archives of psychiatry and clinical neuroscience · 2021
   Review

Corrections and comments

• Comment on
  Fluvoxamine vs Placebo and Clinical Deterioration in Outpatients With Symptomatic COVID-19: A Randomized Clinical Trial.2020

Authors and funding

3 authors.

Funding

No grant is acknowledged in the PubMed record.

Abstract

PubMed holds no abstract for this paper.

Indexed as